The U.S. Food and Drug Administration (FDA) has given Tr1x the green light to launch a first-in-human clinical trial of TRX319, a cell therapy candidate designed to restore immune balance […] The post Tr1x gets OK for first-in-human trial of TRX319 for progressive MS appeared…

The U.S. Food and Drug Administration (FDA) granted fast track designation to EG110A, EG 427‘s DNA-based therapy to treat neurogenic detrusor overactivity (NDO) — a bladder disorder that can arise from […] The post FDA fast tracks DNA therapy for MS-related bladder issue appeared first on…

One of the greatest joys Dan and I have found in living with Multiple Sclerosis is connecting with college students pursuing their careers in healthcare. We’ve had several opportunities this fall to do just that, speaking virtually with College of Medicine students at The Ohio…

Living with multiple sclerosis (MS) often means constantly balancing what your body needs with what your life demands. Some days you’re managing symptoms like fatigue, while other days you’re trying […] The post The importance of compassion while living with MS appeared first on Multiple…

Going through menopause with multiple sclerosis (MS) can be challenging, as the changes that come with this stage of life may interact or occur in tandem with existing MS symptoms. […] The post New research sheds light on multiple sclerosis and menopause appeared first on…

Happy halfway through the week! I hope your week has been great so far, and it only gets better until the weekend returns. My week has been going as well as it can, considering I am still trying to find a job and have almost…

It’s that time of year again! Every year, the Multiple Sclerosis Association of America (MSAA) hosts a digital Art Showcase, displaying the beautiful artwork and heartfelt stories of individuals with MS. Over the years, we have received many wonderful submissions … Continue reading → Source:…

Tweet To develop MS drugs, MS Pharma split MS into liittle pieces to make it easier to get regulatory approval for treatments….It was successful in that MS drugs appeared in the 1980s but the down side was that it makes it harder to get approval…

Seizures in people with multiple sclerosis (MS) may be driven by changes in levels of certain brain signaling molecules, implying that targeting these molecules may be a viable strategy to […] The post Myelin damage may lead to seizures in MS, mouse study finds appeared…

Kernal Biologics has been awarded up to $48 million in funding to accelerate the development of KR-402, a next-generation CAR T-cell therapy for multiple sclerosis (MS) and certain blood cancers. The funds […] The post Kernal gets $48M to develop easier, cheaper CAR T-cell therapies appeared first…